Michelle Yanez - May 5, 2023 Form 4 Insider Report for Inhibitor Therapeutics, Inc. (INTI)

Role
Director
Signature
/s/ Michelle Yanez
Stock symbol
INTI
Transactions as of
May 5, 2023
Transactions value $
$0
Form type
4
Date filed
5/17/2023, 07:09 PM
Previous filing
Dec 22, 2022
Next filing
Aug 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INTI Common Stock Other $0 +796K +18088.85% $0.00 801K May 5, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of common stock of Inhibitor Therapeutics, Inc. were distributed to the members of Hedgepath, LLC ("HPLLC"), pro-rata pursuant to their membership interest in HPLLC.